MARK2 and renal cell carcinoma: A recent study correlated EMT with an increased risk of recurrence and poor OS in RCC patients based on the expression of DCLK1 (a serine/threonine kinase involved in microtubule-mediated neuronal migration and morphogenesis) in RCC tumours [28].